Author response to: Comment on: Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of surgery 2021-01, Vol.108 (1), p.e56-e56
Hauptverfasser: Yamada, S, Fujii, T, Satoi, S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e56
container_issue 1
container_start_page e56
container_title British journal of surgery
container_volume 108
creator Yamada, S
Fujii, T
Satoi, S
description
doi_str_mv 10.1093/bjs/znaa033
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2494885779</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2494885779</sourcerecordid><originalsourceid>FETCH-LOGICAL-c290t-c1cc2ce32e45b110da73b193124c89bdf4af566615cb595c5368d8aba79ca63a3</originalsourceid><addsrcrecordid>eNpNUE1LxDAUDIK46-rJu-TopW7SNG2zt2Xxo7CgBz2X1zR1s7RJTVJ0_Rn-YgOuIDx4b-bNzGEQuqLklhLBls3eL78MAGHsBM0py3mS0rycoXPv94RQRnh6hmaM5RkRnMzR93oKO-uwU360xisc7Apv7DAoE7A1K_y8g8hWy6rCPkztAdsOQ9tq84a1CQ5G5XSwRkGPR5C9DvCp-viKKOgY4vGHDruIjHQqUhLLeCqHwbT4n3lQAXwc7S_QaQe9V5fHvUCv93cvm8dk-_RQbdbbRKaChERSKVOpWKoy3lBKWihYQwWjaSZL0bRdBh3P85xy2XDBJWd52ZbQQCEk5AzYAt385o7Ovk_Kh3rQXqq-B6Ps5Os0E1lZ8qIQUXp9lE7NoNp6dHoAd6j_emQ_FKB2Ig</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2494885779</pqid></control><display><type>article</type><title>Author response to: Comment on: Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><creator>Yamada, S ; Fujii, T ; Satoi, S</creator><creatorcontrib>Yamada, S ; Fujii, T ; Satoi, S</creatorcontrib><identifier>EISSN: 1365-2168</identifier><identifier>DOI: 10.1093/bjs/znaa033</identifier><identifier>PMID: 33640950</identifier><language>eng</language><publisher>England</publisher><subject>Humans ; Paclitaxel ; Pancreatic Neoplasms - drug therapy ; Peritoneal Neoplasms - drug therapy ; Peritoneum</subject><ispartof>British journal of surgery, 2021-01, Vol.108 (1), p.e56-e56</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c290t-c1cc2ce32e45b110da73b193124c89bdf4af566615cb595c5368d8aba79ca63a3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33640950$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamada, S</creatorcontrib><creatorcontrib>Fujii, T</creatorcontrib><creatorcontrib>Satoi, S</creatorcontrib><title>Author response to: Comment on: Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis</title><title>British journal of surgery</title><addtitle>Br J Surg</addtitle><subject>Humans</subject><subject>Paclitaxel</subject><subject>Pancreatic Neoplasms - drug therapy</subject><subject>Peritoneal Neoplasms - drug therapy</subject><subject>Peritoneum</subject><issn>1365-2168</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNUE1LxDAUDIK46-rJu-TopW7SNG2zt2Xxo7CgBz2X1zR1s7RJTVJ0_Rn-YgOuIDx4b-bNzGEQuqLklhLBls3eL78MAGHsBM0py3mS0rycoXPv94RQRnh6hmaM5RkRnMzR93oKO-uwU360xisc7Apv7DAoE7A1K_y8g8hWy6rCPkztAdsOQ9tq84a1CQ5G5XSwRkGPR5C9DvCp-viKKOgY4vGHDruIjHQqUhLLeCqHwbT4n3lQAXwc7S_QaQe9V5fHvUCv93cvm8dk-_RQbdbbRKaChERSKVOpWKoy3lBKWihYQwWjaSZL0bRdBh3P85xy2XDBJWd52ZbQQCEk5AzYAt385o7Ovk_Kh3rQXqq-B6Ps5Os0E1lZ8qIQUXp9lE7NoNp6dHoAd6j_emQ_FKB2Ig</recordid><startdate>20210127</startdate><enddate>20210127</enddate><creator>Yamada, S</creator><creator>Fujii, T</creator><creator>Satoi, S</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20210127</creationdate><title>Author response to: Comment on: Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis</title><author>Yamada, S ; Fujii, T ; Satoi, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c290t-c1cc2ce32e45b110da73b193124c89bdf4af566615cb595c5368d8aba79ca63a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Humans</topic><topic>Paclitaxel</topic><topic>Pancreatic Neoplasms - drug therapy</topic><topic>Peritoneal Neoplasms - drug therapy</topic><topic>Peritoneum</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamada, S</creatorcontrib><creatorcontrib>Fujii, T</creatorcontrib><creatorcontrib>Satoi, S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamada, S</au><au>Fujii, T</au><au>Satoi, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Author response to: Comment on: Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis</atitle><jtitle>British journal of surgery</jtitle><addtitle>Br J Surg</addtitle><date>2021-01-27</date><risdate>2021</risdate><volume>108</volume><issue>1</issue><spage>e56</spage><epage>e56</epage><pages>e56-e56</pages><eissn>1365-2168</eissn><cop>England</cop><pmid>33640950</pmid><doi>10.1093/bjs/znaa033</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier EISSN: 1365-2168
ispartof British journal of surgery, 2021-01, Vol.108 (1), p.e56-e56
issn 1365-2168
language eng
recordid cdi_proquest_miscellaneous_2494885779
source Oxford University Press Journals All Titles (1996-Current); MEDLINE
subjects Humans
Paclitaxel
Pancreatic Neoplasms - drug therapy
Peritoneal Neoplasms - drug therapy
Peritoneum
title Author response to: Comment on: Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T20%3A41%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Author%20response%20to:%20Comment%20on:%20Phase%20I/II%20study%20of%20adding%20intraperitoneal%20paclitaxel%20in%20patients%20with%20pancreatic%20cancer%20and%20peritoneal%20metastasis&rft.jtitle=British%20journal%20of%20surgery&rft.au=Yamada,%20S&rft.date=2021-01-27&rft.volume=108&rft.issue=1&rft.spage=e56&rft.epage=e56&rft.pages=e56-e56&rft.eissn=1365-2168&rft_id=info:doi/10.1093/bjs/znaa033&rft_dat=%3Cproquest_pubme%3E2494885779%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2494885779&rft_id=info:pmid/33640950&rfr_iscdi=true